- |||||||||| dextromethorphan hydrobromide/quinidine sulfate / Generic mfg.
Enrollment closed, Trial primary completion date: Nuedexta for the Treatment of Adults With Autism (clinicaltrials.gov) - Apr 3, 2015 P2, N=20, Active, not recruiting, Active, not recruiting --> Completed Recruiting --> Active, not recruiting | Trial primary completion date: Jun 2015 --> Nov 2015
- |||||||||| Trial completion: SynapDx Autism Gene Expression Analysis Study (STORY) (clinicaltrials.gov) - Dec 19, 2014
P=N/A, N=880, Completed, Recruiting --> Terminated | Trial primary completion date: Dec 2013 --> Dec 2012; Mifne began treating younger patients who could not be diagnosed with the ADOS used in the study Active, not recruiting --> Completed
- |||||||||| Trial completion, Trial primary completion date: SAGA: SynapDx Autism Gene Expression Analysis Study (clinicaltrials.gov) - Dec 19, 2014
P=N/A, N=660, Completed, Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial primary completion date: Nov 2015 --> Dec 2014
- |||||||||| Enrollment closed: Intranasal Oxytocin and Learning in Autism (clinicaltrials.gov) - Dec 6, 2014
P2, N=68, Active, not recruiting, Trial primary completion date: Nov 2014 --> Nov 2015 Recruiting --> Active, not recruiting
- |||||||||| Trial completion, Trial primary completion date: Genetics, Brain Structure and Thinking Skills in Autism (clinicaltrials.gov) - Nov 28, 2014
P=N/A, N=138, Completed, Not yet recruiting --> Completed | Trial primary completion date: Jan 2014 --> Sep 2014 Recruiting --> Completed | Trial primary completion date: Dec 2015 --> Aug 2014
- |||||||||| dextromethorphan hydrobromide/quinidine sulfate / Generic mfg.
Trial primary completion date: Nuedexta for the Treatment of Adults With Autism (clinicaltrials.gov) - Nov 24, 2014 P2, N=20, Recruiting, Recruiting --> Completed | Trial primary completion date: Dec 2015 --> Aug 2014 Trial primary completion date: Aug 2014 --> Jun 2015
- |||||||||| Circadin (melatonin prolonged release) / Lundbeck, Neurim, Flynn Pharma, Grupo Insud, Biocodex, Kuhnil Pharma
Trial primary completion date: Efficacy and Safety of Circadin (clinicaltrials.gov) - Nov 19, 2014 P3, N=120, Recruiting, Trial primary completion date: Aug 2014 --> Jun 2015 Trial primary completion date: Oct 2014 --> Aug 2017
- |||||||||| Trial primary completion date: SAGA: SynapDx Autism Gene Expression Analysis Study (clinicaltrials.gov) - Nov 18, 2014
P=N/A, N=660, Active, not recruiting, Not yet recruiting --> Recruiting | Trial primary completion date: Jul 2013 --> Jan 2015 Trial primary completion date: Apr 2014 --> Nov 2015
|